Ray Dalio’s Ionis Pharmaceuticals IONS Stock Holding History

Ray Dalio’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-67,706	Closed	-$5.36M	–	1122
2025 Q4	$5.36M	Buy	67,706 +24,128	+55%	+$1.82M	0.02%	509
2025 Q3	$2.85M	Buy	+43,578	New	+$2.13M	0.01%	639
2022 Q3	–	Sell	-9,779	Closed	-$362K	–	936
2022 Q2	$362K	Buy	9,779 +2,578	+36%	+$97.2K	﹤0.01%	926
2022 Q1	$267K	Buy	+7,201	New	+$236K	﹤0.01%	944
2021 Q3	–	Sell	-7,981	Closed	-$318K	–	740
2021 Q2	$318K	Buy	+7,981	New	+$313K	﹤0.01%	679

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Ray Dalio's IONS Position: Q1 2026 in Review

Ray Dalio sold out of Ionis Pharmaceuticals (IONS) in Q1 2026, closing a stake of 67,706 shares — an estimated $5.36M sold.

Ray Dalio first reported a position in IONS in Q2 2021 and held it in 5 quarters. The position peaked at $5.36M in Q4 2025. 494 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

Ray Dalio reported no remaining Ionis Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
Ray Dalio sold 67,706 Ionis Pharmaceuticals shares in Q1 2026, an estimated $5.36M.
Ray Dalio first reported a position in Ionis Pharmaceuticals in Q2 2021 and held it in 5 quarters.
Ray Dalio's Ionis Pharmaceuticals position peaked at $5.36M in Q4 2025.
494 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on Bridgewater Associates's 13F filing for Q1 2026, filed 15 May 2026.